Jansen FM, van Linschoten RCA, Kievit W, Smits LJT, et al. Cost-effectiveness analysis of increased adalimumab dose intervals in Crohn's disease patients in stable remission: the randomised controlled LADI trial. J Crohns Colitis 2023 Jun 13:jjad101. doi: 10.1093.
PMID: 37310877